IFF has hired an adviser to help it weigh a potential sale of its pharma solutions unit, Bloomberg’s Kiel Porter, Crystal Tse, and Dinesh Nair report, citing people with knowledge of the matter. The business could bring in over $3.5B in a sale, the authors note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IFF: